HEADER TRANSFERASE 22-JUL-03 1Q1Q TITLE CRYSTAL STRUCTURE OF HUMAN PREGNENOLONE SULFOTRANSFERASE (SULT2B1A) IN TITLE 2 THE PRESENCE OF PAP COMPND MOL_ID: 1; COMPND 2 MOLECULE: SULFOTRANSFERASE FAMILY, CYTOSOLIC, 2B, MEMBER 1 ISOFORM A; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: SULT2B1A; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SULT2B1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)RIL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX-6P-3 KEYWDS SULFOTRANSFERASE, PREGNENOLONE, SULT2B1, PAP, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR K.A.LEE,H.FUDA,Y.C.LEE,M.NEGISHI,C.A.STROTT,L.C.PEDERSEN REVDAT 4 16-AUG-23 1Q1Q 1 REMARK LINK REVDAT 3 11-OCT-17 1Q1Q 1 REMARK REVDAT 2 24-FEB-09 1Q1Q 1 VERSN REVDAT 1 11-NOV-03 1Q1Q 0 JRNL AUTH K.A.LEE,H.FUDA,Y.C.LEE,M.NEGISHI,C.A.STROTT,L.C.PEDERSEN JRNL TITL CRYSTAL STRUCTURE OF HUMAN CHOLESTEROL SULFOTRANSFERASE JRNL TITL 2 (SULT2B1B) IN THE PRESENCE OF PREGNENOLONE AND JRNL TITL 3 3'-PHOSPHOADENOSINE 5'-PHOSPHATE. RATIONALE FOR SPECIFICITY JRNL TITL 4 DIFFERENCES BETWEEN PROTOTYPICAL SULT2A1 AND THE SULT2BG1 JRNL TITL 5 ISOFORMS. JRNL REF J.BIOL.CHEM. V. 278 44593 2003 JRNL REFN ISSN 0021-9258 JRNL PMID 12923182 JRNL DOI 10.1074/JBC.M308312200 REMARK 2 REMARK 2 RESOLUTION. 2.91 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.91 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 21.94 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.3 REMARK 3 NUMBER OF REFLECTIONS : 28494 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.249 REMARK 3 FREE R VALUE : 0.269 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1401 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.08 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 78.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3804 REMARK 3 BIN R VALUE (WORKING SET) : 0.4100 REMARK 3 BIN FREE R VALUE : 0.4060 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.80 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 192 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.029 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2189 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 54 REMARK 3 SOLVENT ATOMS : 7 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 80.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.09000 REMARK 3 B22 (A**2) : 4.09000 REMARK 3 B33 (A**2) : -8.17000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.45 REMARK 3 ESD FROM SIGMAA (A) : 0.74 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.50 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.76 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.180 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 0.970 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.700 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.270 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.100 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.29 REMARK 3 BSOL : 15.30 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : PAP.PAR REMARK 3 PARAMETER FILE 3 : NHE.PAR REMARK 3 PARAMETER FILE 4 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 5 : ION.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : PAP.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : NHE.TOP REMARK 3 TOPOLOGY FILE 5 : WATER.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1Q1Q COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-JUL-03. REMARK 100 THE DEPOSITION ID IS D_1000019806. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-SEP-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU300 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : MIRRORS REMARK 200 OPTICS : MSC YALE MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : R-AXIS REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29928 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.08100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : 0.59800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1EFH REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 72.66 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.8M SODIUM TARTRATE, 0.2M LI2SO4, REMARK 280 0.1M CHES, 4MM PAP, PH 9.0, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 126.12300 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 37.62200 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 37.62200 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 63.06150 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 37.62200 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 37.62200 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 189.18450 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 37.62200 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 37.62200 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 63.06150 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 37.62200 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 37.62200 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 189.18450 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 126.12300 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: NOT KNOWN REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 SER A 3 REMARK 465 PRO A 4 REMARK 465 PRO A 5 REMARK 465 PRO A 6 REMARK 465 PHE A 7 REMARK 465 HIS A 8 REMARK 465 SER A 9 REMARK 465 GLN A 10 REMARK 465 LYS A 11 REMARK 465 PHE A 96 REMARK 465 SER A 97 REMARK 465 LEU A 98 REMARK 465 PRO A 99 REMARK 465 ASP A 100 REMARK 465 GLN A 101 REMARK 465 TYR A 102 REMARK 465 ASP A 297 REMARK 465 PRO A 298 REMARK 465 GLU A 299 REMARK 465 GLU A 300 REMARK 465 ASP A 301 REMARK 465 GLY A 302 REMARK 465 SER A 303 REMARK 465 PRO A 304 REMARK 465 ASP A 305 REMARK 465 PRO A 306 REMARK 465 GLU A 307 REMARK 465 PRO A 308 REMARK 465 SER A 309 REMARK 465 PRO A 310 REMARK 465 GLU A 311 REMARK 465 PRO A 312 REMARK 465 GLU A 313 REMARK 465 PRO A 314 REMARK 465 LYS A 315 REMARK 465 PRO A 316 REMARK 465 SER A 317 REMARK 465 LEU A 318 REMARK 465 GLU A 319 REMARK 465 PRO A 320 REMARK 465 ASN A 321 REMARK 465 THR A 322 REMARK 465 SER A 323 REMARK 465 LEU A 324 REMARK 465 GLU A 325 REMARK 465 ARG A 326 REMARK 465 GLU A 327 REMARK 465 PRO A 328 REMARK 465 ARG A 329 REMARK 465 PRO A 330 REMARK 465 ASN A 331 REMARK 465 SER A 332 REMARK 465 SER A 333 REMARK 465 PRO A 334 REMARK 465 SER A 335 REMARK 465 PRO A 336 REMARK 465 SER A 337 REMARK 465 PRO A 338 REMARK 465 GLY A 339 REMARK 465 GLN A 340 REMARK 465 ALA A 341 REMARK 465 SER A 342 REMARK 465 GLU A 343 REMARK 465 THR A 344 REMARK 465 PRO A 345 REMARK 465 HIS A 346 REMARK 465 PRO A 347 REMARK 465 ARG A 348 REMARK 465 PRO A 349 REMARK 465 SER A 350 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 31 CG CD1 CD2 REMARK 470 LEU A 36 CG CD1 CD2 REMARK 470 LYS A 124 CG CD CE NZ REMARK 470 LYS A 152 CG CD CE NZ REMARK 470 LYS A 166 CG CD CE NZ REMARK 470 LYS A 185 CG CD CE NZ REMARK 470 GLN A 200 CG CD OE1 NE2 REMARK 470 LYS A 219 CG CD CE NZ REMARK 470 ARG A 253 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 254 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 284 CG CD CE NZ REMARK 470 ARG A 287 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 296 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 87 CA - N - CD ANGL. DEV. = -13.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 42 78.51 -69.32 REMARK 500 PRO A 54 146.49 -34.60 REMARK 500 GLU A 71 15.34 43.52 REMARK 500 PRO A 81 -171.42 -61.94 REMARK 500 VAL A 93 73.34 -112.50 REMARK 500 PHE A 116 167.20 -49.78 REMARK 500 THR A 117 108.12 -59.52 REMARK 500 ALA A 119 -15.26 -43.43 REMARK 500 PHE A 121 -37.57 -32.06 REMARK 500 ALA A 125 161.17 -48.39 REMARK 500 PRO A 134 -39.10 -39.31 REMARK 500 PRO A 154 -51.43 -23.70 REMARK 500 PRO A 157 -70.53 -46.25 REMARK 500 GLU A 168 58.91 -98.30 REMARK 500 PHE A 171 -1.36 83.94 REMARK 500 GLN A 200 -77.13 -69.34 REMARK 500 LYS A 219 -57.84 -27.06 REMARK 500 TYR A 242 6.27 58.09 REMARK 500 SER A 248 27.61 -76.66 REMARK 500 LEU A 249 -18.86 -160.11 REMARK 500 ARG A 254 -83.15 -87.35 REMARK 500 LEU A 258 79.08 -106.26 REMARK 500 ARG A 259 -85.36 -55.51 REMARK 500 HIS A 269 -53.06 -126.21 REMARK 500 GLN A 285 -33.85 -132.33 REMARK 500 ARG A 287 -86.12 -16.42 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A 351 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 SER A 145 O REMARK 620 2 ALA A 148 O 82.7 REMARK 620 3 LEU A 151 O 90.7 73.7 REMARK 620 4 ASP A 153 OD1 94.9 172.2 113.8 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA A 351 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE A3P A 352 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NHE A 353 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NHE A 354 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1Q1Z RELATED DB: PDB REMARK 900 SULT2B1B WITH PAP BOUND REMARK 900 RELATED ID: 1Q20 RELATED DB: PDB REMARK 900 SULT2B1B WITH PAP AND PREGNENOLONE BOUND REMARK 900 RELATED ID: 1Q22 RELATED DB: PDB REMARK 900 SULT2B1B STRUCTURE WITH PAP AND DHEA DBREF 1Q1Q A 1 350 UNP O00204 ST2B1_HUMAN 1 350 SEQRES 1 A 350 MET ALA SER PRO PRO PRO PHE HIS SER GLN LYS LEU PRO SEQRES 2 A 350 GLY GLU TYR PHE ARG TYR LYS GLY VAL PRO PHE PRO VAL SEQRES 3 A 350 GLY LEU TYR SER LEU GLU SER ILE SER LEU ALA GLU ASN SEQRES 4 A 350 THR GLN ASP VAL ARG ASP ASP ASP ILE PHE ILE ILE THR SEQRES 5 A 350 TYR PRO LYS SER GLY THR THR TRP MET ILE GLU ILE ILE SEQRES 6 A 350 CYS LEU ILE LEU LYS GLU GLY ASP PRO SER TRP ILE ARG SEQRES 7 A 350 SER VAL PRO ILE TRP GLU ARG ALA PRO TRP CYS GLU THR SEQRES 8 A 350 ILE VAL GLY ALA PHE SER LEU PRO ASP GLN TYR SER PRO SEQRES 9 A 350 ARG LEU MET SER SER HIS LEU PRO ILE GLN ILE PHE THR SEQRES 10 A 350 LYS ALA PHE PHE SER SER LYS ALA LYS VAL ILE TYR MET SEQRES 11 A 350 GLY ARG ASN PRO ARG ASP VAL VAL VAL SER LEU TYR HIS SEQRES 12 A 350 TYR SER LYS ILE ALA GLY GLN LEU LYS ASP PRO GLY THR SEQRES 13 A 350 PRO ASP GLN PHE LEU ARG ASP PHE LEU LYS GLY GLU VAL SEQRES 14 A 350 GLN PHE GLY SER TRP PHE ASP HIS ILE LYS GLY TRP LEU SEQRES 15 A 350 ARG MET LYS GLY LYS ASP ASN PHE LEU PHE ILE THR TYR SEQRES 16 A 350 GLU GLU LEU GLN GLN ASP LEU GLN GLY SER VAL GLU ARG SEQRES 17 A 350 ILE CYS GLY PHE LEU GLY ARG PRO LEU GLY LYS GLU ALA SEQRES 18 A 350 LEU GLY SER VAL VAL ALA HIS SER THR PHE SER ALA MET SEQRES 19 A 350 LYS ALA ASN THR MET SER ASN TYR THR LEU LEU PRO PRO SEQRES 20 A 350 SER LEU LEU ASP HIS ARG ARG GLY ALA PHE LEU ARG LYS SEQRES 21 A 350 GLY VAL CYS GLY ASP TRP LYS ASN HIS PHE THR VAL ALA SEQRES 22 A 350 GLN SER GLU ALA PHE ASP ARG ALA TYR ARG LYS GLN MET SEQRES 23 A 350 ARG GLY MET PRO THR PHE PRO TRP ASP GLU ASP PRO GLU SEQRES 24 A 350 GLU ASP GLY SER PRO ASP PRO GLU PRO SER PRO GLU PRO SEQRES 25 A 350 GLU PRO LYS PRO SER LEU GLU PRO ASN THR SER LEU GLU SEQRES 26 A 350 ARG GLU PRO ARG PRO ASN SER SER PRO SER PRO SER PRO SEQRES 27 A 350 GLY GLN ALA SER GLU THR PRO HIS PRO ARG PRO SER HET NA A 351 1 HET A3P A 352 27 HET NHE A 353 13 HET NHE A 354 13 HETNAM NA SODIUM ION HETNAM A3P ADENOSINE-3'-5'-DIPHOSPHATE HETNAM NHE 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID HETSYN NHE N-CYCLOHEXYLTAURINE; CHES FORMUL 2 NA NA 1+ FORMUL 3 A3P C10 H15 N5 O10 P2 FORMUL 4 NHE 2(C8 H17 N O3 S) FORMUL 6 HOH *7(H2 O) HELIX 1 1 SER A 30 THR A 40 1 11 HELIX 2 2 GLY A 57 LYS A 70 1 14 HELIX 3 3 PRO A 74 VAL A 80 1 7 HELIX 4 4 THR A 117 PHE A 121 5 5 HELIX 5 5 ASN A 133 ALA A 148 1 16 HELIX 6 6 THR A 156 LYS A 166 1 11 HELIX 7 7 SER A 173 ARG A 183 1 11 HELIX 8 8 TYR A 195 ASP A 201 1 7 HELIX 9 9 ASP A 201 LEU A 213 1 13 HELIX 10 10 GLY A 218 THR A 230 1 13 HELIX 11 11 THR A 230 ALA A 236 1 7 HELIX 12 12 GLY A 264 HIS A 269 5 6 HELIX 13 13 THR A 271 LYS A 284 1 14 SHEET 1 A 2 TYR A 16 TYR A 19 0 SHEET 2 A 2 VAL A 22 PRO A 25 -1 O PHE A 24 N PHE A 17 SHEET 1 B 4 LEU A 106 SER A 109 0 SHEET 2 B 4 ILE A 48 ILE A 51 1 N ILE A 48 O MET A 107 SHEET 3 B 4 LYS A 126 GLY A 131 1 O ILE A 128 N PHE A 49 SHEET 4 B 4 PHE A 190 THR A 194 1 O ILE A 193 N TYR A 129 LINK O SER A 145 NA NA A 351 1555 1555 2.60 LINK O ALA A 148 NA NA A 351 1555 1555 2.78 LINK O LEU A 151 NA NA A 351 1555 1555 2.34 LINK OD1 ASP A 153 NA NA A 351 1555 1555 2.39 CISPEP 1 SER A 103 PRO A 104 0 -0.05 SITE 1 AC1 4 SER A 145 ALA A 148 LEU A 151 ASP A 153 SITE 1 AC2 18 LYS A 55 SER A 56 GLY A 57 THR A 58 SITE 2 AC2 18 THR A 59 TRP A 60 ARG A 132 SER A 140 SITE 3 AC2 18 TYR A 195 GLN A 199 SER A 229 PHE A 231 SITE 4 AC2 18 MET A 234 PHE A 257 LEU A 258 ARG A 259 SITE 5 AC2 18 LYS A 260 GLY A 261 SITE 1 AC3 4 TYR A 142 PRO A 157 LEU A 161 HIS A 269 SITE 1 AC4 7 TYR A 29 PRO A 54 TRP A 88 TYR A 144 SITE 2 AC4 7 GLN A 150 GLN A 170 PHE A 171 CRYST1 75.244 75.244 252.246 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013290 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013290 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003964 0.00000